Search

Author/Creator Imhof, Thomas

1. A new MMP‐mediated prodomain cleavage mechanism to activate bone morphogenetic proteins from the extracellular matrix. Issue 3 (25th February 2021)

Authors:
Furlan, Ariane G.; Spanou, Chara E. S.; Godwin, Alan R. F.; Wohl, Alexander P.; Zimmermann, Laura‐Marie A.; Imhof, Thomas; Koch, Manuel; Baldock, Clair; Sengle, Gerhard
Journal:
FASEB journal
Issue:
Volume 35:Issue 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Amyloidogenicity assessment of transthyretin gene variants. Issue 8 (29th July 2022)

Authors:
Grether, Nicolai B.; Napravnik, Felix; Imhof, Thomas; Linke, Reinhold P.; Bräsen, Jan H.; Schmitz, Jessica; Dohrn, Maike; Schneider, Christian; Svačina, Martin K. R.; Stetefeld, Jörg; Koch, Manuel; Lehmann, Helmar C.
Journal:
Annals of clinical and translational neurology
Issue:
Volume 9:Issue 8(2022)
Page Start:
1252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation. Issue 1 (23rd December 2022)

Authors:
Spanou, Chara E. S.; Wohl, Alexander P.; Doherr, Sandra; Correns, Annkatrin; Sonntag, Niklas; Lütke, Steffen; Mörgelin, Matthias; Imhof, Thomas; Gebauer, Jan M.; Baumann, Ulrich; Grobe, Kay; Koch, Manuel; Sengle, Gerhard
Journal:
FASEB journal
Issue:
Volume 37:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗